38 research outputs found

    Comparative analyses on medium optimization using one-factor-at-a-time, response surface methodology, and artificial neural network for lysine–methionine biosynthesis by Pediococcus pentosaceus RF-1

    Get PDF
    Optimization strategy that encompassed one-factor-at-a-time (OFAT), response surface methodology (RSM), and artificial neural network method was implemented during medium formulation with specific aim for lysine-methionine biosynthesis employing a newly isolated strain of Pediococcus pentosaceus RF-1. OFAT technique was used in the preliminary screening of factors (molasses, nitrogen sources, fish meal, glutamic acid and initial medium pH) before proceeded to optimization study. Implementation of central composite design of experiment subsequently generated 30 experimental runs based on four factors (molasses, fish meal, glutamic acid, and initial medium pH). From RSM analysis, a quadratic polynomial model can be devoted to describing the relationship between various medium components and responses. It also suggested that using molasses (9.86 g/L), fish meal (10.06 g/L), glutamic acid (0.91 g/L), and initial medium pH (5.30) would enhance the biosynthesis of lysine (15.77 g/L) and methionine (4.21 g/L). Alternatively, a three-layer neural network topography at 4-5-2 predicted a further improvement in the biosynthesis of lysine (16.52 g/L) and methionine (4.53 g/L) by using formulation composed of molasses (10.02 g/L), fish meal (18.00 g/L), and glutamic acid (1.17 g/L) with initial medium pH (4.26), respectively

    A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above

    Get PDF

    Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

    Get PDF
    Background: Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. // Methods: We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung's disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. // Findings: We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung's disease) from 264 hospitals (89 in high-income countries, 166 in middle-income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in low-income countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. // Interpretation: Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

    Gamma-irradiation of uracil in de-aerated aqueous solutions

    No full text

    Matchmaking model for bilateral trading decisions of load serving entity

    Full text link
    © 2020 Matchmaking and bilateral negotiations are two distinct phases of practical market participants’ decision making for bilateral transactions. Agent-based models are naturally suitable for electricity markets in general and bilateral transactions in particular. This paper's contribution includes development of a novel matchmaking model that generates forward contracting power and utility curves. The matchmaking model enables a load serving entity agent to undertake its own matchmaking, to find optimal trading allocations over a range of prices, before engaging in bilateral negotiations with generation company agents. Open-source agent-based simulation platform allows combined simulation of bilateral transactions and day-ahead auction. In this research paper, matchmaking is achieved by direct-search without any organized bulletin board, broker, or matchmaker. Instead of random matchmaking, portfolio optimization based matchmaking systematically explores available electricity trading options throughout the market: local and non-local bilateral trades as well as day-ahead auctions. The matchmaking algorithm is unique because it scans all trading options over the entire range of negotiable prices. Depending on private profit-seeking goals, risk-aversion preferences and market price statistics, each load serving entity agent individually finds its matchmaking results. A set of case studies demonstrates how matchmaking model depends on transmission rights and performs for different risk aversion factors

    Halal Certification of Food, Nutraceuticals, and Pharmaceuticals in the Arab World

    Full text link
    Food is an organic need and essential to our survival, whereas nutraceuticals and pharmaceuticals play an important role in disease prevention and cure. The food processing and healthcare industries are often linked together for economic growth and health promotion. However, the complexity of the ingredients and processes led communities to question their motivation, accuracy, and imposed standards. Different standards are often applied to ensure high quality, reproducibility, and traceability. Many processed products contain ingredients derived from animals, where the consumption of such products is prohibited by several religions and lifestyles. Patients who want to avoid certain medications derived from animal need to know the source of origin and detailed ingredients contained in their medicines. Recently many Muslim and non-Muslim countries have realized the value of Halal products and led to an increase in Halal awareness. This chapter aims to provide more insight into the issue of Halal status of food and medications in the context of healthcare and describe the process of certification and the list of ingredients and drugs with potential non-Halal sources. Traceability procedure and identification of a long list of ingredients is a challenge but also key for verifying the Halal status of the end product. Implementation of Halal-Tayyib concept is essential to determine the Halalness of food and pharmaceuticals. To increase confidence, eliminate suspicion, and improve trust with producers, Halal certification is required. However, exerting 100% effort is possible, whereas achieving products that are 100% clean and pure and comply with Shari’ah is debatable
    corecore